Larimar Therapeutics, Inc. (LRMR)

Larimar Therapeutics, Inc. (LRMR) is a healthcare company (biotechnology) based in the United States. The share price is $2.99, down 0.33% on the day, which values the company at $310.61M. Price as of 18 Nov 2026, 11:36 UTC, from Yahoo Finance.

Key facts

Share price
$2.99−0.33% today
Market value
$310.61M
200-week average
$4.7036% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Larimar Therapeutics, Inc. in more detail

LRMR trades at -3.3× next year's expected earnings. It sits 36% below its 200-week average of $4.70.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

Larimar Therapeutics, Inc. (LRMR): questions and answers

What is Larimar Therapeutics, Inc.'s market cap?

Larimar Therapeutics, Inc. is valued at $310.61M at a share price of $2.99.

Is LRMR above its 200-week moving average?

No. LRMR is 36.4% below its 200-week average of $4.70. Long-term investors watch that line because strong companies rarely trade below it for long.

Does LRMR pay a dividend?

Larimar Therapeutics, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Larimar Therapeutics, Inc. (LRMR) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/LRMR

Underlying data: Yahoo Finance; company filings with the SEC.